Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
99 100 Next >
TFX Q1 Earnings Call: Guidance Cut and Strategic Shifts Dominate Amid Tariff Headwinds
Via StockStory
Topics Economy World Trade
Tickers TFX
Exposures Product Safety Supply Chain Tariff
PsychedelicNewsBreaks – NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Set to Report Q1 Earnings in Wake of HOPE’s Strategic Kadima Agreement
Via Investor Brand Network
Topics Intellectual Property
Tickers NRXP
Exposures Intellectual Property Product Safety
FDA Fast-Tracks AbbVie's New Lung Cancer Therapy Emrelis For Tough Lung Cancer Cases
Via Benzinga
Tickers ABBV RHHBY
Exposures Product Safety
FDA Approves Merck's Kidney Cancer Drug For Rare Type Of Neuroendocrine Tumors
Via Benzinga
Tickers MRK
Exposures Product Safety
AbbVie Gets FDA Nod For Drug To Treat Lung Cancer: Retail’s Yet To React
Via Stocktwits
Tickers ABBV UNH VOO VTI
Exposures Product Safety
TNDM Q1 Earnings Call: Product Expansion and Channel Initiatives Drive Growth Against Margin Pressures
Via StockStory
Tickers TNDM
Exposures Product Safety
BioMedNewsBreaks — NanoViricides (NYSE American: NNVC) Advances NV-387 Antiviral as Measles and MPox Resurge Globally
Via Investor Brand Network
Topics Intellectual Property
Tickers NNVC
Exposures COVID-19 Intellectual Property Product Safety
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advances PTSD Treatment with FDA-Requested Safety Study for SPC-15
Via Investor Brand Network
Tickers SILO
Exposures Product Safety
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Appoints Joseph Hand as General Counsel and EVP of Operations
Via Investor Brand Network
Tickers TNXP
Exposures Product Safety
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Hits FDA Milestone and Expands Strategic Partnerships in Q1 Update
Via Investor Brand Network
Topics Intellectual Property
Tickers BEAT BMWYY
Exposures Intellectual Property Product Safety
Ford Recalls Nearly 274,000 SUVs In US: Retail Gets More Bearish
Via Stocktwits
Topics Artificial Intelligence Product Recall
Tickers F NVDA SCHD VTI
Exposures Artificial Intelligence Legal Product Safety
Ford Issues Recall Of Over 270,000 Vehicles As Safety Concerns Mount
Via Benzinga
Topics Product Recall
Tickers DRIV F GM IYK
Exposures Legal Product Safety
Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore
Via MarketBeat
Topics Earnings
Tickers KRYS LNTH SRPT WFC
Exposures Financial Product Safety
Waymo Recalls Over 1,200 Robotaxis Over Software Issue: Retail Sentiment Dips On Parent Alphabet
Via Stocktwits
Topics Product Recall
Tickers GOOG GOOGL UAL VTI
Exposures Legal Product Safety
TD Securities Financial Advisor Isabella Gravinese
Via Binary News Network
Topics Artificial Intelligence Economy Retirement
Exposures Artificial Intelligence Interest Rates Pension
Robert Kennedy Jr. Cheers FDA Plan To Ban Fluoride Supplements For Children, Calls Move 'Long Overdue'
Via Benzinga
Exposures Product Safety
Club Cruise™ Reports: Southwest Airlines Ends Open Seating, Adds Bag Fees in Major 2025 Shift
Via 24-7 Press Release
Topics Product Recall
Tickers LUV
Exposures Legal Product Safety
Telepathic iPhone? Apple Steps Into Elon Musk's Neuralink Territory With Bold Brain-Control Tech
Via Stocktwits
Tickers AAPL VTI XLK
Exposures Product Safety
Discover the Future of Non-Invasive Body Sculpting at Scottsdale Med Spa
Via AB Newswire
Exposures Product Safety
Braden Counseling Center Unveils Deep TMS Therapy in Sycamore, IL
Via Press Advantage
Exposures Product Safety
$34 Billion Market in 2025 Advancing to $45 Billion in 2026 for Phase III Development of New Blood Thiner, Less Problematic Than Warfrain: Cadrenal Therapeutics, Inc. (Nasdaq: CVKD)
Via Get News
Topics Death Economy
Tickers ABT CVKD
Exposures Death Product Safety Supply Chain
$34 Billion Market in 2025 Advancing to $45 Billion in 2026 for Phase III Development of New Blood Thinner, Less Problematic Than Warfrain: $CVKD
Via PRLog
Topics Death Economy
Exposures Death Product Safety Supply Chain
Addressing Powdering Issues in PE Film Processing: Constructive Solutions for Enhanced Production
Via AB Newswire
Topics Bonds Product Recall Supply Chain
Exposures Debt Markets Legal Product Safety
TechMediaBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Prepares for Potential Fibromyalgia Drug Approval, Reports Q1 Results
Via Investor Brand Network
Tickers TNXP
Exposures Product Safety
BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics to Acquire Kadima Neuropsychiatry Institute
Via Investor Brand Network
Tickers NRXP
Exposures Product Safety
How SeaStar Medical Joined Select Ranks Of Medical Device Innovators With Six FDA Breakthrough Device Designations
Via NewMediaWire
Tickers ICU
Exposures Product Safety
How SeaStar Medical Joined Select Ranks Of Medical Device Innovators With Six FDA Breakthrough Device Designations
Via TheNewswire.com
Tickers ICU
Exposures Product Safety
Best Biotech Stocks to Buy in 2025
Via MarketBeat
Topics ETFs Economy Government
Tickers AKRO REGN VRTX XBI
Exposures COVID-19 Interest Rates Political
TransMedics Group Stock Is Up 81% in 2025. Can It Climb Even Higher?
Via The Motley Fool
Tickers TMDX
Exposures Product Safety
Thomas D'Aguanno Announces the Release of His Debut Novella StarStruck, Tapping into '90s Nostalgia with the Help of AI
Via Press Release Distribution Service
Topics Artificial Intelligence Intellectual Property Product Recall
Exposures Artificial Intelligence Intellectual Property Layoff
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.